SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Apr 15, 2020
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: April 15, 2020 · CIK: 0001585608 · Accession: 0001104659-20-046823
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236016
Letter
Re: Jaguar Health, Inc. Registration Statement on Form S-1
April 15, 2020
Via EDGAR
Ada D. Sarmento U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
File No. 333-236016
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Thursday, April 16, 2020, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant hereby authorizes each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration.
Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.
Very truly yours,
Jaguar Health, Inc.
Show Raw Text
CORRESP 1 filename1.htm April 15, 2020 Via EDGAR Ada D. Sarmento U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Health, Inc. Registration Statement on Form S-1 File No. 333-236016 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Thursday, April 16, 2020, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration. Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358. Very truly yours, Jaguar Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105 Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · https://jaguar.health